VX680 Suppresses the Growth of HepG2 Cells and Enhances the Chemosensitivity to Cisplatin

Oncology Letters - Greece
doi 10.3892/ol.2013.1648
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Spandidos Publications

Related search

PJ34, an Inhibitor of PARP-1, Suppresses Cell Growth and Enhances the Suppressive Effects of Cisplatin in Liver Cancer Cells

Oncology Reports
MedicineCancer ResearchOncology
1994English

Co-Expression of ING4 and P53 Enhances Hypopharyngeal Cancer Chemosensitivity to Cisplatin in Vivo

Molecular Medicine Reports
OncologyGeneticsMolecular BiologyBiochemistryCancer ResearchMolecular Medicine
2016English

Small-Molecule Inhibitor of BCL-2 (TW-37) Suppresses Growth and Enhances Cisplatin-Induced Apoptosis in Ovarian Cancer Cells

Journal of Ovarian Research
GynecologyOncologyObstetrics
2015English

MicroRNA-126 Enhances the Sensitivity of Osteosarcoma Cells to Cisplatin and Methotrexate

Oncology Letters
Cancer ResearchOncology
2015English

MicroRNA 145 Enhances Chemosensitivity of Glioblastoma Stem Cells to Demethoxycurcumin

Cancer Management and Research
Oncology
2019English

Targeting Survivin Enhances Chemosensitivity in Retinoblastoma Cells and Orthotopic Tumors

PLoS ONE
Multidisciplinary
2016English

Connexin 43 Enhances the Cisplatin-Induced Cytotoxicity in Mesothelioma Cells

2012English

Demethylzeylasteral (ZST93) Inhibits Cell Growth and Enhances Cell Chemosensitivity to Gemcitabine in Human Pancreatic Cancer Cells via Apoptotic and Autophagic Pathways

International Journal of Cancer
Cancer ResearchOncology
2018English

CD133 Antisense Suppresses Cancer Cell Growth and Increases Sensitivity to Cisplatin in Vitro

Experimental and Therapeutic Medicine
MedicineCancer ResearchImmunologyMicrobiology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy